Casey Eye Institute and Devers Eye Institute Collaborative Grand Rounds

When
November 4, 2022
7 a.m. to 8 a.m.
Where

When it's time, join your Webex meeting here.
Join Meeting: https://ohsu.webex.com/ohsu/j.php?MTID=m3d4576ee3bfc6ba1d3f70142bab6d8e1
Meeting password: zRhKEzA9P78

Phone (audio only):
1-503-388-9555 Portland, OR
1-206-207-1700 Seattle, WA
Meeting number (access code): 2624 096 7735
Additional call-in numbers: https://ohsu.webex.com/ohsu/globalcallin.php

Mobile phone (one-touch):
206-207-1700,,26240967735##

Contact Information

Target audience: Ophthalmologists and ophthalmologists in training.

Topic: Anterior Segment Case Conference

Speakers:

Andrea Bordewyk, M.D.
Claire Mueller, M.D.

Learning objectives

Participants will be able to:

  1. Formulate differential diagnosis
  2. Utilize imaging and other testing modalities to aid in diagnosis and monitoring
  3. Determine optimal treatment plan

Accreditation

Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credits

OHSU School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure to Learners

Presenters/Moderators

  • Andrea Bordewyk, M.D. - Nothing to disclose 
  • Emily Jones, M.D. - Nothing to disclose 
  • Claire Mueller, M.D. - Nothing to disclose 

Program Planning Committee

  • Hemakshi Adke - Nothing to Disclose
  • Aiyin Chen, M.D. - Nothing to Disclose
  • Julie Falardeau, M.D. - Nothing to Disclose
  • Seema Gupta, M.D. - Nothing to Disclose
  • Thomas Hwang, M.D. - Nothing to Disclose
  • Susan Minnieweather - Nothing to Disclose
  • Afshan Nanji, M.D. - Nothing to Disclose
  • Amanda Redfern, M.D. - Nothing to Disclose
  • Leah Reznick, M.D. - Nothing to Disclose
  • Lorri Wilson, M.D. - Nothing to Disclose
  • Daniel Tu, M.D., Ph.D. - Nothing to Disclose